Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Debt / NOTE 3/0
-
Market price (% of par)
-
78.75%
-
Total 13F principal
-
$446,406,179
-
Principal change
-
+$32,101,524
-
Total reported market value
-
$346,025,363
-
Number of holders
-
43
-
Value change
-
-$7,021,150,598
-
Number of buys
-
25
-
Number of sells
-
10
Institutional Holders of HAEMONETICS CORP MASS - NOTE 3/0 as of Q2 2022
As of 30 Jun 2022,
HAEMONETICS CORP MASS - NOTE 3/0 was held by
43 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$446,406,179
in principal (par value) of the bond.
The largest 10 bondholders included
FRANKLIN RESOURCES INC, ADVENT CAPITAL MANAGEMENT /DE/, Kohlberg Kravis Roberts & Co. L.P., AVIVA PLC, Aequim Alternative Investments LP, Brandywine Global Investment Management, LLC, OSTERWEIS CAPITAL MANAGEMENT INC, OAKTREE CAPITAL MANAGEMENT LP, GOLDMAN SACHS GROUP INC, and SSI INVESTMENT MANAGEMENT LLC.
This page lists
44
institutional bondholders reporting positions
for the Q2 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.